Singapore's co-developed vaccine candidate is in 'good shape' for delivery in 2021

Positive results were announced by Singapore's Covid vaccine candidate ARCT-021, developed by Arcturus Therapeutics together with Duke-NUS Medical School.

from Health and Science https://ift.tt/2V6o6Mx
https://ift.tt/eA8V8J
https://ift.tt/2zIUzyH